Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep 27;11(19):5708.
doi: 10.3390/jcm11195708.

Survival of Breast Cancer by Stage, Grade and Molecular Groups in Mallorca, Spain

Affiliations

Survival of Breast Cancer by Stage, Grade and Molecular Groups in Mallorca, Spain

Maria Clara Pascual et al. J Clin Med. .

Abstract

The aims of this study are: (1) to determine cause-specific survival by stage, grade, and molecular groups of breast cancer, (2) to identify factors which explain and predict the likelihood of survival and the risk of dying from this cancer; and (3) to find out the distribution of breast cancer cases by stage, grade, and molecular groups in females diagnosed in the period 2006-2012 in Mallorca (Spain). We collected data regarding age, date and diagnostic method, histology, laterality, sublocation, pathological or clinical tumor size (T), pathological or clinical regional lymph nodes (N), metastasis (M) and stage, histologic grade, estrogen and progesterone receptors status, HER-2 expression, Ki67 level, molecular classification, date of last follow-up or date of death, and cause of death. We identified 2869 cases. Cause-specific survival for the entire sample was 96% 1 year after diagnosis, 91% at 3 years and 87% at 5 years. Relative survival was 96.9% 1 year after diagnosis, 92.6% at 3 years and 88.5% at 5 years. The competing-risks regression model determined that patients over 65 years of age and patients with triple negative cancer have worse prognoses, and as stages progress, the prognosis for breast cancer worsens, especially from stage III.

Keywords: breast cancer; competing-risks regression model; multiple imputation; survival.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Survival curves of breast cancer by (a) age and (b) histology.
Figure 2
Figure 2
Survival curves of breast cancer by (a) laterality, (b) sublocation, (c) stage, (d) histologic grade and (e) molecular classification, before and after Multiple Imputation (MI) (m = 5).
Figure 2
Figure 2
Survival curves of breast cancer by (a) laterality, (b) sublocation, (c) stage, (d) histologic grade and (e) molecular classification, before and after Multiple Imputation (MI) (m = 5).

References

    1. Cancer Today. [(accessed on 13 March 2022)]. Available online: https://gco.iarc.fr/today/home.
    1. Redecan. [(accessed on 13 March 2022)]. Available online: https://redecan.org/es.
    1. Sant M., Lopez M.D.C., Agresti R., Pérez M.J.S., Holleczek B., Bielska-Lasota M., Dimitrova N., Innos K., Katalinic A., Langseth H., et al. Survival of women with cancers of breast and genital organs in Europe 1999–2007: Results of the EUROCARE-5 study. Eur. J. Cancer. 2015;51:2191–2205. doi: 10.1016/j.ejca.2015.07.022. - DOI - PubMed
    1. Chirlaque M.D., the REDECAN Working Group. Salmerón D., Galceran J., Ameijide A., Mateos A., Torrella A., Jiménez R., Larrañaga N., Marcos-Gragera R., et al. Cancer survival in adult patients in Spain. Results from nine population-based cancer registries. Clin. Transl. Oncol. 2018;20:201–211. doi: 10.1007/s12094-017-1710-6. - DOI - PubMed
    1. Fei F., Zhang K., Siegal G.P., Wei S. A simplified breast cancer prognostic score: Comparison with the AJCC clinical prognostic staging system. Mod. Pathol. 2021;34:2141–2147. doi: 10.1038/s41379-021-00890-y. - DOI - PubMed